The risk was 2.5 times higher for migraine sufferers who experienced aura (visual disturbances such as flashing lights, zigzag lines and blurred vision), and for women experiencing aura, 2.9 times higher. (criticalillnessinsuranceinfo.org)
Women suffer from migraines at a much higher rate than men, with females making up about 70 percent of migraine sufferers in the United States. (wallerwellness.com)
A new study of fremanezumab, an immunotherapy that counteracts one of the molecules released during migraine, was found successful in reducing the number of days that chronic migraine sufferers experienced headaches. (sciencedaily.com)